{"title":"Gene and RNA Editing: Methods, Enabling Technologies, Applications, and Future Directions","authors":"Mohammed Aledhari, Mohamed Rahouti","doi":"arxiv-2409.09057","DOIUrl":null,"url":null,"abstract":"Gene and RNA editing methods, technologies, and applications are emerging as\ninnovative forms of therapy and medicine, offering more efficient\nimplementation compared to traditional pharmaceutical treatments. Current\ntrends emphasize the urgent need for advanced methods and technologies to\ndetect public health threats, including diseases and viral agents. Gene and RNA\nediting techniques enhance the ability to identify, modify, and ameliorate the\neffects of genetic diseases, disorders, and disabilities. Viral detection and\nidentification methods present numerous opportunities for enabling\ntechnologies, such as CRISPR, applicable to both RNA and gene editing through\nthe use of specific Cas proteins. This article explores the distinctions and\nbenefits of RNA and gene editing processes, emphasizing their contributions to\nthe future of medical treatment. CRISPR technology, particularly its adaptation\nvia the Cas13 protein for RNA editing, is a significant advancement in gene\nediting. The article will delve into RNA and gene editing methodologies,\nfocusing on techniques that alter and modify genetic coding. A-to-I and C-to-U\nediting are currently the most predominant methods of RNA modification. CRISPR\nstands out as the most cost-effective and customizable technology for both RNA\nand gene editing. Unlike permanent changes induced by cutting an individual's\nDNA genetic code, RNA editing offers temporary modifications by altering\nnucleoside bases in RNA strands, which can then attach to DNA strands as\ntemporary modifiers.","PeriodicalId":501070,"journal":{"name":"arXiv - QuanBio - Genomics","volume":"42 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - QuanBio - Genomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2409.09057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Gene and RNA editing methods, technologies, and applications are emerging as
innovative forms of therapy and medicine, offering more efficient
implementation compared to traditional pharmaceutical treatments. Current
trends emphasize the urgent need for advanced methods and technologies to
detect public health threats, including diseases and viral agents. Gene and RNA
editing techniques enhance the ability to identify, modify, and ameliorate the
effects of genetic diseases, disorders, and disabilities. Viral detection and
identification methods present numerous opportunities for enabling
technologies, such as CRISPR, applicable to both RNA and gene editing through
the use of specific Cas proteins. This article explores the distinctions and
benefits of RNA and gene editing processes, emphasizing their contributions to
the future of medical treatment. CRISPR technology, particularly its adaptation
via the Cas13 protein for RNA editing, is a significant advancement in gene
editing. The article will delve into RNA and gene editing methodologies,
focusing on techniques that alter and modify genetic coding. A-to-I and C-to-U
editing are currently the most predominant methods of RNA modification. CRISPR
stands out as the most cost-effective and customizable technology for both RNA
and gene editing. Unlike permanent changes induced by cutting an individual's
DNA genetic code, RNA editing offers temporary modifications by altering
nucleoside bases in RNA strands, which can then attach to DNA strands as
temporary modifiers.